Cargando…

Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons

Complex genetic predispositions accelerate the chronic degeneration of midbrain substantia nigra neurons in Parkinson’s disease (PD). Deciphering the human molecular makeup of PD pathophysiology can guide the discovery of therapeutics to slow the disease progression. However, insights from human pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Hurk, Mark, Lau, Shong, Marchetto, Maria C., Mertens, Jerome, Stern, Shani, Corti, Olga, Brice, Alexis, Winner, Beate, Winkler, Jürgen, Gage, Fred H., Bardy, Cedric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579158/ https://www.ncbi.nlm.nih.gov/pubmed/36258029 http://dx.doi.org/10.1038/s41531-022-00400-0

Ejemplares similares

Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
por: Stern, Shani, et al.
Publicado: (2022)

Patch-Seq Protocol to Analyze the Electrophysiology, Morphology and Transcriptome of Whole Single Neurons Derived From Human Pluripotent Stem Cells
por: van den Hurk, Mark, et al.
Publicado: (2018)

Corrigendum: Patch-Seq Protocol to Analyze the Electrophysiology, Morphology and Transcriptome of Whole Single Neurons Derived From Human Pluripotent Stem Cells
por: van den Hurk, Mark, et al.
Publicado: (2019)

Editorial: Advances in neural reprogramming, disease modeling and therapeutic insights
por: Lau, Shong, et al.
Publicado: (2023)

Prediction of response to drug therapy in psychiatric disorders
por: Stern, Shani, et al.
Publicado: (2018)

Modeling Parkinson’s disease in midbrain-like organoids
por: Smits, Lisa M., et al.
Publicado: (2019)

Sporadic Parkinson’s disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs
por: Schulze, Markus, et al.
Publicado: (2018)

Age-Related Midbrain Inflammation and Senescence in Parkinson’s Disease
por: Russo, Taylor, et al.
Publicado: (2022)

A monocyte gene expression signature in the early clinical course of Parkinson’s disease
por: Schlachetzki, Johannes C. M., et al.
Publicado: (2018)

Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
por: Tran, Jenne, et al.
Publicado: (2020)

Author Correction: A monocyte gene expression signature in the early clinical course of Parkinson’s disease
por: Schlachetzki, Johannes C. M., et al.
Publicado: (2020)

Adult Hippocampal Neurogenesis in Parkinson's Disease: Impact on Neuronal Survival and Plasticity
por: Regensburger, Martin, et al.
Publicado: (2014)

Midbrain Organoids: A New Tool to Investigate Parkinson’s Disease
por: Smits, Lisa Maria, et al.
Publicado: (2020)

Immunohistochemical Analysis of Mitochondrial Ferritin in the Midbrain of Patients with Parkinson’s Disease
por: Tsubaki, Haruka, et al.
Publicado: (2023)

Janus-faced spatacsin (SPG11): involvement in neurodevelopment and multisystem neurodegeneration
por: Pozner, Tatyana, et al.
Publicado: (2020)

Interaction of Alpha Synuclein and Microtubule Organization Is Linked to Impaired Neuritic Integrity in Parkinson’s Patient-Derived Neuronal Cells
por: Seebauer, Lukas, et al.
Publicado: (2022)

Pathological priming causes developmental gene network heterochronicity in autism patient-derived neurons
por: Schafer, Simon T., et al.
Publicado: (2019)

The Gut–Immune–Brain Axis: An Important Route for Neuropsychiatric Morbidity in Inflammatory Bowel Disease
por: Masanetz, Rebecca Katharina, et al.
Publicado: (2022)

Genetics of NLRP3 suggests lack of involvement and inefficient druggability in Parkinson’s disease
por: Senkevich, Konstantin, et al.
Publicado: (2023)

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease
por: Galet, Benjamin, et al.
Publicado: (2020)

Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease
por: Steidel, Kenan, et al.
Publicado: (2022)

Your Brain Under the Microscope: The Promise of Stem Cells
por: Marchetto, Maria C., et al.
Publicado: (2014)

KRAS: Druggable at Last
por: Herzberg, Benjamin O, et al.
Publicado: (2023)

Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients’ neurons
por: Havlicek, Steven, et al.
Publicado: (2014)

Focal (123)I-FP-CIT SPECT Abnormality in Midbrain Vascular Parkinsonism
por: Solla, Paolo, et al.
Publicado: (2015)

The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
por: Qarin, Shamma, et al.
Publicado: (2021)

Targeted activation of midbrain neurons restores locomotor function in mouse models of parkinsonism
por: Masini, Débora, et al.
Publicado: (2022)

Proteins and Transcriptional Dysregulation of the Brain Extracellular Matrix in Parkinson’s Disease: A Systematic Review
por: Rike, Wote Amelo, et al.
Publicado: (2023)

The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets
por: Hassan, Syed S., et al.
Publicado: (2018)

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
por: Storm, Catherine S., et al.
Publicado: (2021)

Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease
por: Kohl, Zacharias, et al.
Publicado: (2010)

Modeling Cell-Cell Interactions in Parkinson’s Disease Using Human Stem Cell-Based Models
por: Simmnacher, Katrin, et al.
Publicado: (2020)

Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons
por: Vahedi, Shahrooz, et al.
Publicado: (2010)

Activin A Protects Midbrain Neurons in the 6-Hydroxydopamine Mouse Model of Parkinson’s Disease
por: Stayte, Sandy, et al.
Publicado: (2015)

WNT signaling in midbrain dopaminergic neuron development and cell replacement therapies for Parkinson’s disease
por: Arenas, Ernest, et al.
Publicado: (2015)

Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease
por: Li, Yanxuan, et al.
Publicado: (2020)

Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease
por: Carmichael, Kathleen, et al.
Publicado: (2021)

Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
por: Virdi, Gurvir S., et al.
Publicado: (2022)

microRNAs profiling of small extracellular vesicles from midbrain tissue of Parkinson’s disease
por: Li, Zhengzhe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eberrebr992tjjuvo1pmv3q5hg